Navigation Links
Mutant gene causes severe kidney disease in infants

Scientists at the University of Michigan Medical School have discovered a previously unknown cause for a severe, early-onset form of kidney disease and renal failure in children: recessive mutations in a gene called phospholipase C epsilon or PLCE1.

Identifying the mutant gene is important to scientists because PLCE1 affects the development of podocytes ?specialized cells that play a vital role in the kidney's ability to remove waste products from blood, while retaining important blood proteins.

To parents of infants with inherited PLCE1 mutations, the study is especially significant because it provides the first evidence that some types of a kidney disease called nephrotic syndrome, if diagnosed early in infancy, may be treated successfully in children.

"This is the first report of infants with two mutations in a recessive gene for steroid-resistant nephrotic syndrome who nevertheless responded to steroid treatment," says Friedhelm Hildebrandt, M.D., the U-M's Frederick G L Huetwell Professor for the Cure and Prevention of Birth Defects. "The early onset form of the disease is severe and infants often go into end-stage renal disease within the first year of life. So, until now, most physicians believed there was no point in trying treatment."

The study will be published Nov. 5 in Nature Genetics as an Advance Online Publication, and will be printed in the journal's December 2006 issue.

There are many types and many causes of nephrotic syndrome, but basically it is a disease of the glomerulus, the kidney's main blood filtration unit. There are about one million of these filtration units in each human kidney. As blood flows through a network of tiny capillaries in the glomerulus, excess water, salts and toxic molecules are removed and flushed out in urine, while important blood proteins like albumin are retained in the bloodstream. If the kidney's filtering units don't work properly, nephrotic syndrome develops. Protei
'"/>

Source:University of Michigan Health System


Page: 1 2 3 4

Related biology news :

1. Mutant mice show key autism traits
2. Mutant mouse provides insights into breast cancer
3. BRCA1 causes ovarian cancer through indirect, biochemical route
4. Researchers discover molecule that causes secondary stroke
5. NASA study finds snow melt causes large ocean plant blooms
6. Alarm pheromone causes aphids to sprout wings
7. One hit of crystal meth causes birth defects
8. University of Nevada, Reno research team discovers hormone that causes malaria mosquito to urinate
9. Gene discovery sheds light on causes of rare disease, cancer
10. Defect in gene causes neuralgic amyotrophy
11. Genomics researchers discover protein deficit that causes drug toxicity

Post Your Comments:
(Date:11/4/2009)...rstCall/ -- BIO-key International, Inc. (OTC Bulle...ic identification software is showcasing donor and...rence being held at the New Orleans Convention Cen...hands-on product demonstrations of its state-of-th...o, at 5 PM on Monday, October 26, Peter Lux, manag...
(Date:11/4/2009)...encoe Software, Inc., the commercial arm of the Op...://openmicroscopy.org ), is proud to announce its...iology,s exciting new project titled "The Cell: An... stimulus grant through the National Institutes of...rt of the American Reinvestment and Recovery Act, ...
(Date:11/3/2009)...published in a recent issue of HortTechnology , s...the effects of covering orchard floors with reflec...ight distribution, orchard temperature, and profit...nday and Solarmate films installed 5 weeks before ...pples. The research showed that the use of both fi...
Breaking Biology News(10 mins):BIO-key(R) International Exhibiting at AABB TXPO 2Glencoe Software to Support the ASCB 'Stimulus Grant' to Build Virtual Image Library of the Cell 2Reflective film can boost profits for apple growers 2China Medical Technologies Announces the Substantial Completion of an Independent Internal Investigation and Expected Timing of Reporting of Unaudited 53242 1China Medical Technologies Announces the Substantial Completion of an Independent Internal Investigation and Expected Timing of Reporting of Unaudited 53242 2China Medical Technologies Announces the Substantial Completion of an Independent Internal Investigation and Expected Timing of Reporting of Unaudited 53242 3China Medical Technologies Announces the Substantial Completion of an Independent Internal Investigation and Expected Timing of Reporting of Unaudited 53242 4Learning Takes Place When You Get Things Right 53240 1Learning Takes Place When You Get Things Right 53240 2The First SamarionSolution Installed in Lake Charles Alzheimers Facility 53237 1The First SamarionSolution Installed in Lake Charles Alzheimers Facility 53237 2
...anes, submarines and even automobiles of tomorrow ...rformance micro-mechanical gyroscopes for navigati...EMS gyroscope arrays being developed by a team con...avrik of Oak Ridge National Laboratory is radicall... and costly. Instead, this system consists of mult...
...this summer where the tiger,s roar will meet birds...ll be heard next door to advanced sonar systems; w... the smashing falls of Antarctic ice shelves. , ...d to them -- will only be found at the Acoustics,0... Friday July 4, 2008 at the Palais des Congrs in P...
...r Medical Research, led by Jos Luis Milln, Ph.D., ... of enzyme replacement therapy to prevent hypophos...tic origin. This discovery lays the foundation fo...ckets is a softening of the bones that most common... from insufficient exposure to sunlight. Hypophosp...
Other Biology News:Story tips from the Department of Energy's Oak Ridge National Laboratory, June 2008 2Story tips from the Department of Energy's Oak Ridge National Laboratory, June 2008 3Potential therapy discovered for hypophosphatasia, a congenital form of rickets 2
(Date:11/6/2009)... CALGARY, Nov. 6 /PRNewswire-FirstCall/ - Oncolyti...s" or the "Company") today announced updated resul...) in patients with sarcomas metastatic to the lung...ctive Tissue Oncology Society Meeting held in Miam...ster presentation, entitled "A Phase II Study of I...
(Date:11/5/2009)...TRANSPORTATION -- Gone hybrid . . . , Fuel eco...es are now posted at the www.fueleconomy.gov web...ed and maintains for the U.S. Department of Energy...e of the top 10 vehicles on the best fuel economy ... (51 MPG city; 48 highway). "This list proves that...
(Date:11/5/2009)... PARSIPPANY, N.J., Nov. 5 DSM Phar...de a manufacturing alliance with Galenix, Saint Je...d commercial scale manufacturing partner for Galen...M and Galenix will collaborate on business develop...ery technologies, based on the strength of Galenix...
(Date:11/5/2009)... Conference Call on Thursday, November 5, 2009 at ...OUVER Nov. 5 /PRNewswire-FirstCall/ - OncoGenex Ph... (NASDAQ: OGXI ) today reported unaudited financi...nded September 30, 2009 and reviewed the Company,s...he following consolidated results reflect the oper...
Breaking Biology Technology:Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 2November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 3DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3OncoGenex Reports Third Quarter 2009 Financial Results 2OncoGenex Reports Third Quarter 2009 Financial Results 3OncoGenex Reports Third Quarter 2009 Financial Results 4OncoGenex Reports Third Quarter 2009 Financial Results 5OncoGenex Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 7OncoGenex Reports Third Quarter 2009 Financial Results 8
...chnologies,Corporation, a leader in tumor-targeted...l European patents for the platform targeting tech...on gene delivery to primary cancers and,metastatic...h profound,demonstrations of clinical benefit and ...Epeius Biotech continues to lead the field of clin...
...siva,Inc. (Nasdaq: ANSV ) today announced top-li...ng Adlea(TM), its long-acting, non-opioid analgesi...dpoint of reducing post-surgical,pain versus place..., or total,knee replacement surgery) at four to 48...econdary endpoint with Adlea demonstrating a highl...
...alize Colorectal Cancer Treatment Determining Who ...KS, Calif., Dec. 16 Amgen (Nasdaq: AMGN ) today ...f the KRAS gene as a predictive biomarker in pat...ated with anti-epidermal growth factor receptor (E....S. Food and Drug Administration,s (FDA) Oncologic...
Other Biology Technology:Epeius Biotech Awarded Patents in Europe for Targeted Genetic Anti-Cancer Medicine: Company Expands Impressive Intellectual Property Estate 2Anesiva Phase 3 Trial of Adlea Meets Primary Endpoint to Significantly Reduce Pain After Total Knee Replacement Surgery 2Anesiva Phase 3 Trial of Adlea Meets Primary Endpoint to Significantly Reduce Pain After Total Knee Replacement Surgery 3Anesiva Phase 3 Trial of Adlea Meets Primary Endpoint to Significantly Reduce Pain After Total Knee Replacement Surgery 4Oncology Biomarker KRAS to be Discussed at FDA Panel Meeting 2Oncology Biomarker KRAS to be Discussed at FDA Panel Meeting 3Oncology Biomarker KRAS to be Discussed at FDA Panel Meeting 4Oncology Biomarker KRAS to be Discussed at FDA Panel Meeting 5Oncology Biomarker KRAS to be Discussed at FDA Panel Meeting 6Oncology Biomarker KRAS to be Discussed at FDA Panel Meeting 7Oncology Biomarker KRAS to be Discussed at FDA Panel Meeting 8
Rabbit Anti-Bcl-G, C-Terminus Polyclonal Antibody, Unconjugated from AnaSpec
Rabbit Anti-Mouse sRANKL Antibody, Biotin Conjugated from Cell Sciences
Rabbit Anti-L-isoleucine Antibody, Unconjugated from QED Bioscience Inc.
Anti-TIMP-4 (Tissue Inhibitor of Metalloproteinases-4), Loop #3 Polyclonal Antibody, Unconjugated from CHEMICON
Biology Products: